Table 2.
The Effect Of HIV On The Serum Concentration Level Of Micronutrient To Discriminate Active TB From Healthy Control Study Participants (M0)
| Micronutrient Name | HIV+TB+ (n=57) |
TB (n=87) | HIV+TST– (n=71) |
TST– (n=25) | P-Value | |
|---|---|---|---|---|---|---|
| HIV+TB+vs TB | HIV+TST– vs TST– | |||||
| Iron (µg/mL) | 0.23(0.19–0.36) | 0.25(0.21–0.37) | 0.58(0.36–0.84) | 0.90(0.76–1.03) | 0.3212 | 0.0005 |
| Vitamin B12 (pg/mL) | 655(491–869) | 627(479–829) | 402(329–512) | 360(257–566) | 0.6350 | 0.3942 |
| Vitamin A (µmol/L) | 0.6(0.4–0.9) | 0.7(0.5–1.3) | 1.4(1.1–1.7) | 1.5(1.1–1.6) | 0.0983 | 0.8588 |
Notes: Median (interquartile range) micronutrient level values are shown at baseline and significant differences between active TB with and without HIV, HIV infection and controls were determined using the Wilcoxon Mann–Whitney test. P-values for the comparison between the groups are shown.